Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review
Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review
July 20, 2023
Read the full article here:
News
Outcome Capital Expands Life Science and Healthcare Advisory Capabilities with Addition of Dr. David Feygin to Medical Device, Digital Health and AI Practices
BOSTON–(BUSINESS WIRE)–Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced the addition of Dr. David Feygin as a Senior Advisor to the firm’s Medical Device, Digital Health and AI practices. The appointment expands Outcome Capital’s strategic advisory capabilities in the rapidly evolving intersection of life sciences, healthcare, […]
Read MoreResources
Outcome Capital Life Science Market Pulse
Outcome Capital Life Science Market Pulse April 2026 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
